Researchers have created decoys of platelets - the body's clot-forming blood cells - that prevented the formation of dangerous blood clots in vessels (or thrombosis) and combated cancer metastasis in preclinical models. Their decoys - whose effects can be reversed far faster compared to standard antiplatelet drugs - represent a promising therapeutic strategy for treating thrombosis and cancer metastasis, two leading causes of death and disability worldwide.
Platelets play a vital role in the human circulatory system, as they protect the body from bleeding and maintain the integrity of blood vessels. However, hyperactive platelets also contribute to an array of diseases - patients with thrombosis often have elevated platelet counts, which can also promote the spread of malignant cancer cells.
Currently available antiplatelet drugs can inhibit platelet activation, but reversal of the effects they exert requires at least one week, making them risky for patients who have suffered a trauma or other life-threatening situations. To overcome this obstacle, researchers created a rapidly reversible antiplatelet therapy inspired by platelet "decoys."
The decoys did not aggregate and became activated in the same manner as normal platelets but maintained their ability to interact with other cells. They also inhibited harmful adhesion and aggregation of functional platelets and reduced the severity of thrombosis in a rabbit model. Importantly their effects were immediately reversed with an injection of fresh, functional platelets.
They also displayed wide-ranging anticancer effects - the decoys broke up platelet-mediated aggregation of human breast cancer cells, prevented their spread in a chip model of the human vasculature, and inhibited metastatic tumor growth in mice. The fast reversibility of the therapy indicates it could one day prevent life-threatening bleeding in clinical emergencies or surgical settings, the authors say.
http://stm.sciencemag.org/content/11/479/eaau5898
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Mouse pups with human mutation show signs of stuttering
Read more
Mechanism behind brains derailed train of thought
Read more
Effect of progressive weight loss on metabolic functions
Read more
Alcohol exposure during pregnancy affects multiple generations
Read more
Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Deriv…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar